The FDA on May 21 approved Dova Pharmaceuticals’ drug Doptelet to treat thrombocytopenia — a condition involving a low blood platelet count — in chronic liver disease patients set to undergo a medical ...
News-Medical.Net on MSN
Study reports the world's first genetically engineered pig-to-human liver xenotransplantation
An important new study in the Journal of Hepatology, published by Elsevier, reports the world's first auxiliary liver ...
Please provide your email address to receive an email when new articles are posted on . In 2023, nearly a third of hospitalized patients with chronic liver disease had acute kidney injury or ...
A new study in the Journal of Hepatology reports on an auxiliary liver xenotransplant from a genetically engineered pig to a ...
Patients with chronic liver disease (MASLD) who also have high blood pressure, prediabetes or diabetes, or low HDL cholesterol face the greatest risk. More than one in three people worldwide live with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback